Health ❯ Regulatory Affairs

Drug Approval Process

FDA Regulations Health Canada FDA Review European Medicines Agency Market Competition

EU Regulators Back Uplizna as First Treatment for IgG4‑Related Disease

The CHMP opinion now goes to the European Commission for an EU‑wide decision.

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition